These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1687493)

  • 1. Expression of c-myc, epidermal growth factor receptor and c-erbB-2 in human endometrial carcinoma and cervical adenocarcinoma.
    Sato S; Ito K; Ozawa N; Yajima A; Sasano H
    Tohoku J Exp Med; 1991 Oct; 165(2):137-45. PubMed ID: 1687493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
    Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
    Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
    Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
    Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
    Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
    Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical investigation and northern blot analysis of c-erB-2 expression in normal, premalignant and malignant tissues of the corpus and cervix uteri.
    Brumm C; Rivière A; Wilckens C; Löning T
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(6):477-84. PubMed ID: 1980167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas.
    Pääkkö P; Nuorva K; Kamel D; Soini Y
    Am J Respir Cell Mol Biol; 1992 Sep; 7(3):325-34. PubMed ID: 1355655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Demonstration and biological significance of viral and cellular oncogenes in uterine carcinomas].
    Milde-Langosch K; Wilckens C; Brack T; Löning T
    Verh Dtsch Ges Pathol; 1991; 75():363-5. PubMed ID: 1724842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressions of c-erbB-2, epidermal growth factor receptor and pan-ras proto-oncogenes in adenocarcinoma of the cervix: correlation with clinical prognosis.
    Leung TW; Cheung AN; Cheng DK; Wong LC; Ngan HY
    Oncol Rep; 2001; 8(5):1159-64. PubMed ID: 11496335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
    Nagai N; Oshita T; Fujii T; Kioka H; Katsube Y; Ohama K
    Oncol Rep; 2000; 7(3):551-9. PubMed ID: 10767367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of bcl-2, bax-xL, and bcl-xS in endometrial and cervical tissues.
    Mozzetti S; Ferrandina G; Marone M; D'Ingiullo F; Fruscella E; De Pasqua A; Mancuso S; Scambia G
    Cancer Detect Prev; 2000; 24(6):536-41. PubMed ID: 11198267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status.
    Wang D; Konishi I; Koshiyama M; Mandai M; Nanbu Y; Ishikawa Y; Mori T; Fujii S
    Cancer; 1993 Nov; 72(9):2628-37. PubMed ID: 8104681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of epidermal growth factor receptor (EGFR) and c-erbB-2 protein overexpression in adenocarcinoma of the uterine cervix.
    Altavilla G; Castellan L; Wabersich J; Marchetti M; Onnis A
    Eur J Gynaecol Oncol; 1996; 17(4):267-70. PubMed ID: 8856301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy.
    Shen L; Shui Y; Wang X; Sheng L; Yang Z; Xue D; Wei Q
    BMC Cancer; 2008 Aug; 8():232. PubMed ID: 18700025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD105 microvessels density, VEGF, EGFR-1 and c-erbB-2 and their prognostic correlation in different subtypes of cervical adenocarcinoma.
    Barbu I; Crăiţoiu S; Simionescu CE; Drâgnei AM; Mărgăritescu C
    Rom J Morphol Embryol; 2013; 54(3):519-30. PubMed ID: 24068399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression in head and neck squamous cell carcinomas.
    Kearsley JH; Leonard JH; Walsh MD; Wright GR
    Pathology; 1991 Jul; 23(3):189-94. PubMed ID: 1685773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification and over-expression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas.
    al-Kasspooles M; Moore JH; Orringer MB; Beer DG
    Int J Cancer; 1993 May; 54(2):213-9. PubMed ID: 8098013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix.
    Ueda A; Takasawa A; Akimoto T; Takasawa K; Aoyama T; Ino Y; Nojima M; Ono Y; Murata M; Osanai M; Hasegawa T; Saito T; Sawada N
    PLoS One; 2017; 12(8):e0184123. PubMed ID: 28859123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical study of epidermal growth factor receptor, transforming growth factor alpha, and "squamous differentiation" in human endometrial carcinoma.
    Santini D; Ceccarelli C; Martinelli GN; Leone O; Marabini A; Orlandi C; Mancini AM
    Hum Pathol; 1994 Dec; 25(12):1319-23. PubMed ID: 7528164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.